The global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1% during the forecast period. Rising adoption of flow cytometry in clinical applications in developing & developed countries coupled with increased stem cell research activities are some of the major factors projecting the market growth.
Flow cytometry market is fragmented and competitive in nature, several market players are adopting strategies to sustain market competition. The companies offer various instruments, services, software’s, reagents & consumables for flow cytometry. Prominent players in the global flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Luminex Corporation (US), and among others.
To know about the assumptions considered for the study download the pdf brochure
BECTON, DICKINSON AND COMPANY (US)
BD is the leading player in the flow cytometry market. The company offers a significant number of products and consistently backs product launches with technological innovation. The company’s focus on innovative, user-friendly software solutions for flow cytometry has helped maintain its dominant position in the market. Various factors such as the launch of technologically advanced instruments and a strong global presence are attributable to the dominance of BD in the flow cytometry market. The company launched the FACSymphony A5 SE Cell Analyzer. This fluorescence-activated and spectral-enabled cell analyzer allows researchers to choose between spectral or compensation-based cell analysis to meet different flow cytometry needs in 2021.
The company’s wide presence worldwide has also played an important role in securing its position in the market. In 2021, the operating income of the BD Life Sciences segment grew to 39.7%, from 8.7% in 2020. To maintain its leading position and enhance its market share, the company mainly focuses on exceeding customer expectations by maintaining the quality of its services and quickly & efficiently adapting to new conditions.
DANAHER CORPORATION (US)
Danaher Corporation is one of the leading players in the flow cytometry market. In June 2011, Danaher (US) acquired Beckman Coulter, Inc. Danaher designs, manufactures, and markets medical, industrial, and commercial products and services through four business segments, namely, Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. This company primarily strategizes its growth through acquisitions, key collaborations, and product launches. Beckman Coulter significantly contributes to Danaher’s revenue through innovative research, advancement, expansion, and the launch of novel flow cytometry products. The company has a significant number of product launches and acquisitions in the flow cytometry market, especially in 2019 and 2021. This indicates the company’s focused strategy to emerge as a leader in the market in the coming years.
Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE